To test this hypothesis, we used the ferroptosis inducer Erastin, necroptosis inducer Nigericin, apoptosis inducer Hydroxyurea, and autophagy inducer Wogonoside to induce cell death in BC cells, followed by the addition of recombinant NRG1 protein to observe its effect on cell viability. This evidence concerns the gene NRG1 and breast cancer.